NCT07448337Not yet recruiting
Psoriasis Comorbidities at Hospital Calderón Guardia
Prevalence of Metabolic Comorbidities, Atherosclerotic Arterial Disease, and Psoriatic Arthritis in Patients With Psoriasis and Their Association With Clinical Severity and Therapeutic Profile Among Patients Treated at Hospital Rafael Ángel Calderón Guardia During 2024-2025
Source: ClinicalTrials.gov · Last updated 8 Apr 2026
Brief summary (registry, in English)
The goal of this observational study is to characterize the epidemiologic, clinical, severity, and therapeutic features of patients with psoriasis treated in Costa Rica between 2024 and 2025. The main questions it aims to answer are: What are the demographic and clinical characteristics and severity profiles of psoriasis patients? What treatments are used in routine clinical practice, and how are they associated with disease severity and outcomes? Patients with psoriasis receiving dermatologic care during the study period will be included. Data will be obtained retrospectively from electronic medical records and clinical registries without intervention or modification of treatment.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 350 (estimated)
- First submitted
- 26 Feb 2026
- Start date
- 1 May 2026
- Primary completion date
- 31 May 2027
- Lead sponsor
- Caja Costarricense de Seguro Social
- Diseases
- Psoriasis, Psoriatic arthritis
- NCT number
- NCT07448337
What you commit to
- Study type: Observational
- Planned participants: 350
- From 1 May 2026 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients managed exclusively with topical therapies.
Other illness
- Cutaneous conditions not compatible with psoriasis.
Other
- Clinical records insufficient to evaluate psoriasis severity, comorbidities, or therapeutic profile.
- Duplicate or inconsistent records, preventing accurate patient classification.
Who the study is looking for
- Patients evaluated in outpatient clinics during the period 2024-2025.
- Patients receiving systemic therapy and/or phototherapy.
- Patients aged 12 years or older, of any sex.
- Availability of sufficient clinical information to assess psoriasis severity, metabolic comorbidities, atherosclerotic cardiovascular disease, and psoriatic arthritis.
- At least one dermatologic or rheumatologic evaluation recorded in the Electronic Health Record (EHR-EDUS) during the study period.
- Confirmed diagnosis of psoriasis documented in the Electronic Health Record (EHR-EDUS) of Hospital Calderón Guardia.
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Caja Costarricense del Seguro Social Coordinator of this site? Confirm its status | San José | Costa Rica | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.